Finally, we assessed the prognostic value of the elevated Gal-3 levels in plasma (adjuvant; n = 45) and tumor stroma (neoadjuvant; n = 31) through Kaplan-Meier survival analysis after 84-month follow-up of study patients (Figures 4(a) and 4(b); Figure 5). Here, LGALS3 is linked to neoplasm.